Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group
Annals of Oncology, 07/17/09
Sperr WR et al. - The data show that comorbidity is an important risk factor for OS and EFS in patients with MDS.
Related Articles
Prognostic molecular markers in myelodysplastic syndromes
Expert Review of Hematology, 10/22/09
Relevance Score: 68%
Hematopoiesis-related microRNA expression in myelodysplastic syndromes
Leukemia and Lymphoma, 11/06/09
Relevance Score: 67%
Clinical significance of Th1/Th2 ratio in patients with myelodysplastic syndrome
International Journal of Laboratory Hematology, 10/28/09
Relevance Score: 66%
Accelerated cellular senescence in myelodysplastic syndrome
Experimental Hematology, 10/22/09
Relevance Score: 66%
Relationship of differential gene expression profiles in CD34+ myelodysplastic syndrome marrow cells to disease subtype and progression
Blood, 10/09/09
Relevance Score: 66%
Today in Myeloproliferative Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Pulmonary Alveolar Proteinosis as a Terminal Complication in a Case of Myelodysplastic Syndrome with idic(20q-)
Acta Haematologica, 12/04/09
Environmental-mediated drug resistance: a target for multiple myeloma therapy
Expert Review of Hematology, 12/02/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


